<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>a./Great regional differences were observed in the vasospastic effect of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Namely, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> was far more potent in the middle cerebral artery than in the mesenteric artery. b./The role of <z:chebi fb="3" ids="29103">potassium ions</z:chebi> as well as activation of calcium mobilizing adrenergic, serotoninergic and PGF2 alpha smooth muscle receptors were excluded in the mechanism of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> induced by <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>. c./First in the literature we showed that <z:chebi fb="28" ids="16684">atropine</z:chebi> significantly attenuates the vasospastic effect of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, and <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> releases peptidergic <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> and modulators from nerve terminals that are located in the adventitia of the middle cerebral artery </plain></SENT>
</text></document>